Literature DB >> 21989808

The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients.

Marina Sagud, Matea Nikolac, Alma Mihaljevic-Peles, Gordana Nedic, Bjanka Vuksan Cusa, Maja Mustapic, Miro Jakovljevic, Dorotea Muck-Seler, Nela Pivac.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21989808     DOI： 10.1007/s00213-011-2528-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  8 in total

1.  Pharmacological profile of neuroleptics at human monoamine transporters.

Authors:  M Tatsumi; K Jansen; R D Blakely; E Richelson
Journal:  Eur J Pharmacol       Date:  1999-03-05       Impact factor: 4.432

2.  Sex differences, season of birth and platelet 5-HT levels in schizophrenic patients.

Authors:  D Mück-Seler; N Pivac; M Jakovljević
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

3.  Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group.

Authors:  D G Daniel; D L Zimbroff; S G Potkin; K R Reeves; E P Harrigan; M Lakshminarayanan
Journal:  Neuropsychopharmacology       Date:  1999-05       Impact factor: 7.853

4.  Suicide attempt, smoking, comorbid depression, and platelet serotonin in alcohol dependence.

Authors:  Korona Nenadic-Sviglin; Gordana Nedic; Matea Nikolac; Dragica Kozaric-Kovacic; Tamara Stipcevic; Dorotea Muck Seler; Nela Pivac
Journal:  Alcohol       Date:  2010-12-17       Impact factor: 2.405

5.  Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.

Authors:  A W Schmidt; L A Lebel; H R Howard; S H Zorn
Journal:  Eur J Pharmacol       Date:  2001-08-17       Impact factor: 4.432

Review 6.  The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.

Authors:  Stephen M Stahl; Darius K Shayegan
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

7.  The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features.

Authors:  O Moeller; S Evers; J Deckert; B T Baune; U Dannlowski; D H Nguyen; V Arolt; G Hetzel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-07-03       Impact factor: 5.067

8.  The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression.

Authors:  Dorotea Mück-Seler; Nela Pivac; Marina Sagud; Miro Jakovljević; Alma Mihaljević-Peles
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-12       Impact factor: 5.067
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.